Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Bangkok Dusit Medical Services PCL EV-to-EBITDA?
Bangkok Dusit Medical Services PCLBDUUF 90 EV-to-EBITDA is 11.83 as of Aug. 15, 2026, which is 38% below its 10-year median of 19.12. GuruFocus rates BDUUF with a GF Score™ of 90/100 and a GF Value™ of $0.82. The stock has 2 warning signs investors should review. Among 511 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks worse than 54.21% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bangkok Dusit Medical Services PCL's enterprise value is $9,921 Mil.
Bangkok Dusit Medical Services PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $839 Mil. Therefore, Bangkok Dusit Medical Services PCL's EV-to-EBITDA for today is 11.83.
BDUUF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.95 Med: 19.12 Max: 24.36
Current: 12.18
During the past 13 years, the highest EV-to-EBITDA of Bangkok Dusit Medical Services PCL was 24.36. The lowest was 10.95. And the median was 19.12.
BDUUF's EV-to-EBITDA is ranked worse than 54.21% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs BDUUF: 12.18
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bangkok Dusit Medical Services PCL (OTCPK:BDUUF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bangkok Dusit Medical Services PCL's PE Ratio (TTM) for today is calculated as:
Bangkok Dusit Medical Services PCL's share price for today is $0.6433.
Bangkok Dusit Medical Services PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.029.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL EV-to-EBITDA Chart
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's EV-to-EBITDA falls into.
Bangkok Dusit Medical Services PCL's current Enterprise Value is $9,921 Mil.
Bangkok Dusit Medical Services PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $839 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL (BDUUF) has a EV-to-EBITDA of 11.83 as of Aug. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bangkok Dusit Medical Services PCL. This is 38% below median its historical median of 19.12. Over the past decade, Bangkok Dusit Medical Services PCL's EV-to-EBITDA has ranged from 10.95 to 24.36. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #277 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 54.2%.
Is Bangkok Dusit Medical Services PCL's EV-to-EBITDA too high?
Bangkok Dusit Medical Services PCL's current EV-to-EBITDA of 11.83 is 38% below median its 10-year median of 19.12. Over the past 10 years, this metric has ranged from a low of 10.95 to a high of 24.36. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. Bangkok Dusit Medical Services PCL's value of 11.83 is 9.9% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #277 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #277 out of 511 companies for EV-to-EBITDA. This places Bangkok Dusit Medical Services PCL in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. Bangkok Dusit Medical Services PCL's value of 11.83 is 9.9% above this benchmark. Historically, Bangkok Dusit Medical Services PCL's own EV-to-EBITDA has ranged from 10.95 to 24.36 over the past decade. While the company's 10-year median is 19.12 vs. the industry median of 10.76, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current EV-to-EBITDA of 11.83 is 9.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bangkok Dusit Medical Services PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current EV-to-EBITDA is 11.83, which is 38% below median its own 10-year median of 19.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Bangkok Dusit Medical Services PCL (BDUUF) has a current EV-to-EBITDA of 11.83. The stock's GF Value™ is $0.82, compared to a current price of $0.64 — trading 21.5% below its estimated fair value. The current EV-to-EBITDA is 11.83, which is 38% below median its 10-year median of 19.12 and 9.9% above the Healthcare Providers & Services industry median of 10.76. Bangkok Dusit Medical Services PCL's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDUUF), the current EV-to-EBITDA is 11.83 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDUUF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.64 is trading 21.5% below its estimated GF Value™ of $0.82.
Key valuation signals for BDUUF:
EV-to-EBITDA: 11.83 (38% below median its 10-year median of 19.12)
GF Value™: $0.82 vs. price of $0.64 (21.5% below fair value)
Industry Position: 9.9% above the Healthcare Providers & Services median (#277 of 511)
No single metric tells the full story. See the BDUUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
90GF Score
Get the complete analysis for BDUUF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDUUF has been successfully added to your 
